Table 2. Comparison of Quality Indicators Between Male and Female Patients With ACS in Different Accreditation Status Hospitals.
| Quality indicators | Accreditation classificationa | |||||
|---|---|---|---|---|---|---|
| Before | Undergoing | After | ||||
| Men (n = 175 002) | Women (n = 81 680) | Men (n = 144 763) | Women (n = 71 602) | Men (n = 429 496) | Women (n = 193 356) | |
| Onset-FMC, median (IQR), min | 206 (74-1124) | 304 (100-1684) | 194 (70-934) | 272 (94-1450) | 206 (76-992) | 308 (106-1540) |
| Onset-EMS, median (IQR), min | 58 (18-170) | 84 (26-296) | 52 (18-160) | 74 (24-246) | 58 (20-176) | 86 (30-316) |
| Non-PCI stay, median (IQR), min | 90 (44-218) | 108 (50-284) | 88 (44-200) | 100 (50-274) | 86 (42-198) | 100 (48-246) |
| Statin at arrival | 112 329 (73.8) | 50 111 (71.3) | 94 712 (74.1) | 44 386 (71.4) | 315 115 (80.6) | 138 041 (78.9) |
| DAPT discharge | 12 645 (88.7) | 6190 (86.9) | 19 639 (89.1) | 9593 (87.4) | 183 183 (92.8) | 80 776 (90.3) |
| Statin discharge | 12 532 (87.9) | 6193 (87.0) | 19 404 (88.1) | 9549 (87.0) | 180 217 (91.3) | 80 179 (89.7) |
| PCI for STEMI | 47 105 (61.1) | 12 659 (53.2) | 35 797 (62.5) | 10 230 (55.3) | 129 080 (70.3) | 35 655 (65.1) |
| PCI for high risk of NSTE-ACS | 46 492 (57.2) | 20 805 (43.0) | 41 807 (55.9) | 18 994 (42.1) | 128 339 (60.4) | 56 403 (46.9) |
| Door to balloon, median (IQR), min | 88 (60-130) | 92 (62-136) | 70 (44-100) | 72 (46-104) | 70 (46-100) | 72 (48-106) |
| Door to catheterization laboratory activation, median (IQR), min | 44 (24-72) | 46 (26-78) | 34 (16-54) | 34 (16-56) | 34 (18-54) | 36 (18-56) |
| In-hospital heart failure | 18 977 (12.3) | 11 005 (15.3) | 13 813 (10.5) | 8292 (12.9) | 35 094 (8.7) | 18 826 (10.4) |
| In-hospital mortality | 3396 (1.9) | 2221 (2.7) | 2738 (1.9) | 1782 (2.5) | 7656 (1.8) | 4802 (2.5) |
Abbreviations: ACS, acute coronary syndrome; DAPT, dual antiplatelet therapy; NSTE, non–ST-segment elevation; onset-EMS, time from symptom onset to calling emergency medical service; onset-FMC, time from symptom onset to first medical contact; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction.
a
Unless otherwise indicated, data are expressed as No. (%) of patients. Denominators were varied according to the different missing rates of outcome variables (eTable 3 in Supplement 1). Data for DAPT and statin discharge were collected from June 2019 to December 2020.